Concepedia

The Role of Serum Inflammation-Based Factors in Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion and Its Subtypes

Jie Rao, Na Wu, Xiaoyong Qu, Yuxiang Hu, Yajun Wu, Yi Cheng, Yan Li, Hui Huang, Siyu Li, Ling Shi,

Ophthalmic Research · 2020 · 13 citations · 26 references

DOIFull text

Open access

Abstract

Higher pretreatment PLR was associated with BCVA in patients with RVO-ME and its subtypes who were treated with anti-VEGF drugs. The PLR may be used as a predictive and prognostic tool for effective intravitreal injection treatment outcomes.

References

26

The Prevalence of Retinal Vein Occlusion: Pooled Data from Population Studies from the United States, Europe, Asia, and Australia

Sophie Rogers, Rachel McIntosh, Ning Cheung et al. · Ophthalmology · 2009 · 1.1K citations · Full text

, , +8

Which White Blood Cell Subtypes Predict Increased Cardiovascular Risk?

Benjamin D. Horne, Jeffrey L. Anderson, Jerry M. John et al. · Journal of the American College of Cardiology · 2005 · 963 citations

, , +7

Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer

Stephen Bagley, Shawn Kothari, Charu Aggarwal et al. · Lung Cancer · 2017 · 520 citations

, , +8

Pathogenesis of Macular Edema With Branch Retinal Vein Occlusion and Intraocular Levels of Vascular Endothelial Growth Factor and Interleukin-6

Hidetaka Noma, Hideharu Funatsu, Makiko Yamasaki et al. · American Journal of Ophthalmology · 2005 · 373 citations

, , +7

SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB

Robert L. Avery, Alessandro Castellarin, Nathan Steinle et al. · Retina · 2017 · 318 citations · Full text